Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults

  1. Flavia Camponovo
  2. Joseph J Campo
  3. Timothy Q Le
  4. Amit Oberai
  5. Christopher Hung
  6. Jozelyn V Pablo
  7. Andy A Teng
  8. Xiaowu Liang
  9. B Kim Lee Sim
  10. Said Jongo
  11. Salim Abdulla
  12. Marcel Tanner
  13. Stephen L Hoffman
  14. Claudia Daubenberger
  15. Melissa A Penny  Is a corresponding author
  1. Swiss Tropical and Public Health Institute, Switzerland
  2. Antigen Discovery Inc, United States
  3. Sanaria Inc, United States
  4. Ifakara Health Institute, United Republic of Tanzania
  5. University of Basel, Switzerland

Abstract

Tanzanian adult male volunteers were immunized by direct venous inoculation with radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum (Pf) sporozoites (PfSPZ Vaccine) and protective efficacy assessed by homologous controlled human malaria infection (CHMI). Serum immunoglobulin G (IgG) responses were analyzed longitudinally using a Pf protein microarray covering 91% of the proteome, providing first insights into naturally acquired and PfSPZ Vaccine-induced whole parasite antibody profiles in malaria pre-exposed Africans. Immunoreactivity was identified against 2,239 functionally diverse Pf proteins, showing a wide breadth of humoral response. Antibody-based immune 'fingerprints' in these individuals indicated a strong person-specific immune response at baseline, with little changes in the overall humoral immunoreactivity pattern measured after immunization. The moderate increase in immunogenicity following immunization and the extensive and variable breadth of humoral immune response observed in the volunteers at baseline suggest that pre-exposure reduces vaccine-induced antigen reactivity in unanticipated ways.

Data availability

All data analyzed during this study are included in the manuscript and supporting files, or sited accordingly when published elsewhere

Article and author information

Author details

  1. Flavia Camponovo

    Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
    Competing interests
    No competing interests declared.
  2. Joseph J Campo

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Joseph J Campo, is an employee of Antigen Discovery, Inc.
  3. Timothy Q Le

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Timothy Q Le, is an employee of Antigen Discovery, Inc.
  4. Amit Oberai

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Amit Oberai, is an employee of Antigen Discovery, Inc.
  5. Christopher Hung

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Christopher Hung, is an employee of Antigen Discovery, Inc.
  6. Jozelyn V Pablo

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Jozelyn V Pablo, is an employee of Antigen Discovery, Inc.
  7. Andy A Teng

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Andy A Teng, is an employee of Antigen Discovery, Inc.
  8. Xiaowu Liang

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Xiaowu Liang, is an employee of Antigen Discovery, Inc.
  9. B Kim Lee Sim

    Process Development and Manufacturing, Sanaria Inc, Rockville, United States
    Competing interests
    B Kim Lee Sim, This author is affiliated with Sanaria Inc. Sanaria manufactured PfSPZ Vaccine and PfSPZ Challenge.
  10. Said Jongo

    Interventions and Clinical Trials Unit, Bagamoyo Branch, Ifakara Health Institute, Dar es Salam, United Republic of Tanzania
    Competing interests
    No competing interests declared.
  11. Salim Abdulla

    Interventions and Clinical Trials Unit, Bagamoyo Branch, Ifakara Health Institute, Dar es Salam, United Republic of Tanzania
    Competing interests
    No competing interests declared.
  12. Marcel Tanner

    Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
    Competing interests
    No competing interests declared.
  13. Stephen L Hoffman

    Process Development and Manufacturing, Sanaria Inc, Rockville, United States
    Competing interests
    Stephen L Hoffman, This author is employed by Sanaria. Sanaria Inc. manufactured PfSPZ Vaccine and PfSPZ Challenge. Thus, all authors associated with Sanaria have potential conflicts of interest..
  14. Claudia Daubenberger

    University of Basel, Basel, Switzerland
    Competing interests
    No competing interests declared.
  15. Melissa A Penny

    Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
    For correspondence
    melissa.penny@unibas.ch
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4972-593X

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PP00P3_170702)

  • Melissa A Penny

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Camponovo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,583
    views
  • 198
    downloads
  • 19
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Flavia Camponovo
  2. Joseph J Campo
  3. Timothy Q Le
  4. Amit Oberai
  5. Christopher Hung
  6. Jozelyn V Pablo
  7. Andy A Teng
  8. Xiaowu Liang
  9. B Kim Lee Sim
  10. Said Jongo
  11. Salim Abdulla
  12. Marcel Tanner
  13. Stephen L Hoffman
  14. Claudia Daubenberger
  15. Melissa A Penny
(2020)
Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults
eLife 9:e53080.
https://doi.org/10.7554/eLife.53080

Share this article

https://doi.org/10.7554/eLife.53080

Further reading

    1. Epidemiology and Global Health
    Xiaoning Wang, Jinxiang Zhao ... Dong Liu
    Research Article

    Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. We have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the ECs in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that reduced foxo1a mediated the excessive angiogenesis induced by monosaccharides via upregulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Amanda C Perofsky, John Huddleston ... Cécile Viboud
    Research Article

    Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals, but the contribution of this process to variability in annual epidemics is not well understood. Here, we link influenza A(H3N2) virus evolution to regional epidemic dynamics in the United States during 1997—2019. We integrate phenotypic measures of HA antigenic drift and sequence-based measures of HA and NA fitness to infer antigenic and genetic distances between viruses circulating in successive seasons. We estimate the magnitude, severity, timing, transmission rate, age-specific patterns, and subtype dominance of each regional outbreak and find that genetic distance based on broad sets of epitope sites is the strongest evolutionary predictor of A(H3N2) virus epidemiology. Increased HA and NA epitope distance between seasons correlates with larger, more intense epidemics, higher transmission, greater A(H3N2) subtype dominance, and a greater proportion of cases in adults relative to children, consistent with increased population susceptibility. Based on random forest models, A(H1N1) incidence impacts A(H3N2) epidemics to a greater extent than viral evolution, suggesting that subtype interference is a major driver of influenza A virus infection ynamics, presumably via heterosubtypic cross-immunity.